Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection

By Gorse G.J.   Patel G.B.   Arbuckle J.A.   Belshe R.B.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 383-397

Elsevier

Access to resources Recommend Favorite

Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1)

By Montero M.   Menendez A.   del Carmen Dominguez M.   Navea L.   Vilarubia O.L.   Quintana D.   Izquierdo M.   Jimenez V.   Reyes O.   Lobaina L.   Noa E.   Duarte C.A.  

Vaccine, Vol. 15, Iss. 11, 1997-08 ,pp. : 1200-1208

Elsevier

Access to resources Recommend Favorite

Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems

By Sjolander S.   Hansen J.-E.S.   Lovgren-Bengtsson K.   &   9kerblom L.   Morein B.  

Vaccine, Vol. 14, Iss. 4, 1996-03 ,pp. : 344-352

Elsevier

Access to resources Recommend Favorite

Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus

By McLain L.   Durrani Z.   Wisniewski L.A.   Porta C.   Lomonossoff G.P.   Dimmock N.J.  

Vaccine, Vol. 14, Iss. 8, 1996-06 ,pp. : 799-810

Elsevier

Access to resources Recommend Favorite

Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B' strains by recombinant Mycobacterium bovis BCG-based candidate vaccine

By Chujoh Y.   Matsuo K.   Yoshizaki H.   Nakasatomi T.   Someya K.   Okamoto Y.   Naganawa S.   Haga S.   Yoshikura H.   Yamazaki A.   Yamazaki S.   Honda M.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 797-804

Elsevier

Access to resources Recommend Favorite